55
Participants
Start Date
February 11, 2013
Primary Completion Date
June 15, 2019
Study Completion Date
July 29, 2019
Cisplatin-5FU-Afatinib
2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital, Athens
Dept of Medical Oncology, 251 Air Force Hospital, Athens
"2nd Dept of Internal Medicine, General Hospital of Athens Hippokratio", Athens
"Oncology Section, Dept of Clinical Therapeutics, General Hospital of Athens Alexandra", Athens
"Division of Oncology, 2nd Dept of Internal Medicine, University Hospital Attikon", Athens
2nd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens
3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens
3rd Dept of Medical Oncology, Hygeia Hospital, Athens
1st Dept of Medical Oncology, Metropolitan Hospital, Athens
2nd Dept of Medical Oncology, Metropolitan Hospital, Athens
Division of Oncology, Dept of Internal Medicine, University Hospital of Patras, Pátrai
Dept of Medical Oncology, Ioannina University Hospital, Ioannina
Dept of Medical Oncology, Papageorgiou General Hospital, Thessaloniki
Dept of Medical Oncology, Thermi Clinic S.A, Thessaloniki
Dept of Medical Oncology, University Hospital of Heraklion, Heraklion
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Hellenic Cooperative Oncology Group
OTHER